Hall of Fame trainer Jerry Hollendorfer threatens to have grade I winners on both coasts April 6 as he ships Sahara Sky to Aqueduct Racetrack for the $400,000 Carter Handicap (gr. I).
- Bay Colt
- Born 2009
While Comma to the Top registered his biggest win in the 2010 CashCall Futurity (gr. I), the Bwana Charlie gelding has placed in three straight graded stakes, including a clear victory in the Daytona Stakes to close out 2012
Godolphin's Consortium will miss the March 3 Gotham Stakes (gr. III) and is off the Derby trail after suffering a chip in his right front ankle, trainer Kiaran McLaughlin said.
The $400,000 Gotham (gr. III) at Aqueduct March 3 will likely feature more than a dozen 3-year-olds, headed by 2011 juvenile champion Hansen.
Champion Royal Delta works six furlongs in 1:16.30 Feb. 9 at Payson Park on her way toward the Dubai World Cup (UAE-I). At Palm Meadows, Godolphin's Consortium drills a half-mile in :50.90.
Withers Stakes (gr. III) winner Alpha is likely to stay in New York for his next start, trainer Kiaran McLaughlin said the morning after the Godolphin colt defeated an overmatched field Feb. 4 at Aqueduct.
All eyes will be on juvenile champion Hansen Jan. 29 as he begins his much-anticipated Triple Crown quest in the $400,000 Holy Bull Stakes (gr. III) at Gulfstream Park.
- By Steve Haskin
Steve reveals his pedigree Derby Dozen. read blog
Kendall Hansen and Sky Chai Racing's undefeated 3-year-old Hansen is still on target to launch his campaign in the $400,000 Holy Bull Stakes (gr. III) Jan. 29 at Gulfstream Park.
Starlight Racing's 2-year-old colt Algorithms ran his record to two-for-two with an impressive victory at Gulfstream Park Dec. 16.
The Racing Medication and Testing Consortium received $100,000 contributions from the New York Racing Association and the United States Trotting Association, and $50,000 contributions from the Delaware Thoroughbred Horsemen's Association and the Hambletonian Society, the organization announced July 26.
The Racing Medication and Testing Consortium expects to have enough money to carry it through 2006, but an official with the group indicated it's imperative more racetrack and horsemen's associations commit funds to the organization.
The Delaware Thoroughbred Racing Commission has approved model uniform medication rules as recommended by regulators in the Mid-Atlantic region and hopes to have blood-gas testing for "milkshakes" in place by the time Delaware Park opens April 30 for its 135-day meet.
The Racing Medication and Testing Consortium has set a deadline for adoption of recommended uniform medication violations and testing protocol for "milkshakes," which are mixtures of bicarbonate of soda and a liquid force-fed to a racehorse before it competes.
Dan Fick, executive vice president and executive director of The Jockey Club, was elected chairman of the Racing Medication and Testing Consortium at its quarterly meeting Sept. 9. The consortium also approved a per-start fee for horse owners to help fund initiatives.
The National Horsemen's Benevolent and Protective Association has adopted a position paper on medication and drug-testing that says any changes in policies in each jurisdiction should be enacted only after there is scientific evidence specific therapeutic drugs shouldn't be used in racehorses.
The Racing Medication and Testing Consortium has approved policy language on race-day use of Salix and non-steroidal anti-inflammatory drugs, as well as environmental contaminants, and also formed a subcommittee to review race-day security practices.
Regulators in the United States will get their first look at a proposed national medication and drug-testing policy Dec. 10, but even if it wins widespread support, it could take some time before any changes are enacted in various jurisdictions.
The Racing Medication and Testing Consortium has made substantial progress on a model policy for the horse racing industry and also has allocated $275,000 for four research projects tied to its initiatives.
The Racing Medication and Drug Testing Consortium reached unanimous agreement Tuesday on several sections of a model drug-testing policy that will be brought to various state regulatory agencies for review later this year.
With a goal to raise $2 million to $3 million a year to support its initiatives, the Racing Medication and Testing Consortium is looking at a mechanism that would raise money from horsemen and racetracks based on the top four finishers in each race.
Uniformity in medication and drug testing could be years away, a member of the Racing Medication and Testing Consortium said April 1 during a California Horse Racing Board Medication Committee meeting.
The Racing Medication and Testing Consortium has elected officers, chosen an executive director, and put the finishing touches on few sections of its proposed model policy for medication and drug testing. Breeders' Cup president D.G. Van Clief Jr. was elected chairman.
The Thoroughbred Horsemen's Association on Nov. 27 issued a list of recommendations that call for a restructuring of medication use and drug testing procedures in horse racing. Among them are formation of a non-profit consortium that would be funded via a per-start fee for every Thoroughbred, Standardbred, and Quarter Horse.